OCTAGON CAPITAL ADVISORS LP

PrivateCIK: 1839435
Location

NEW YORK, NY

๐Ÿ“‹ What this filing means

OCTAGON CAPITAL ADVISORS LP filed this quarterly 13Fโ€‘HR report disclosing 35 equity positions with a total reported market value of $579.4K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

35
Positions
$579.4K
Total AUM (reported)
25.26M
Total Shares

Allocation by class

TOTAL AUM$579.4K35 positions
COM$440.2K76.0%
COM NEW$44.1K7.6%
SHS$38.8K6.7%
S&P BIOTECH$19.3K3.3%
SPONSORED ADS$14.0K2.4%
CL A$11.4K2.0%
SPONSORED ADR$10.1K1.8%

Portfolio Concentration

Top 350.2%4โ€“1026.8%11โ€“2520.0%Rest2.9%TOP 1077.1%0%100%
Top 3$290.9K50.2%
4โ€“10$155.6K26.8%
11โ€“25$116.0K20.0%
Rest$16.9K2.9%

Top 3 weight

50.2%

Top 10 weight

77.1%

Voting Authority Distribution

Total shares with voting rights: 25.26M

Sole

Full voting authority

25.26M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole35
Shared0
Other0
Dominant voting typeSole ยท 100.0% of voting shares
Institutional Holdings35
Rows:

APELLIS PHARMACEUTICALS INC

SOLE
COM
Shares2.50M
TypeSH
Market value$171.0K
29.50%
Sole
2.50M
Shared
0.00
None
0.00

ARCUS BIOSCIENCES INC

SOLE
COM
Shares2.67M
TypeSH
Market value$69.8K
12.05%
Sole
2.67M
Shared
0.00
None
0.00

CHINOOK THERAPEUTICS INC

SOLE
COM
Shares2.55M
TypeSH
Market value$50.2K
8.66%
Sole
2.55M
Shared
0.00
None
0.00

HORIZON THERAPEUTICS PUB L

SOLE
SHS
Shares624.50K
TypeSH
Market value$38.6K
6.67%
Sole
624.50K
Shared
0.00
None
0.00

GOSSAMER BIO INC

SOLE
COM
Shares2.05M
TypeSH
Market value$24.5K
4.23%
Sole
2.05M
Shared
0.00
None
0.00

TANDEM DIABETES CARE INC

SOLE
COM NEW
Shares474.93K
TypeSH
Market value$22.7K
3.92%
Sole
474.93K
Shared
0.00
None
0.00

CELLDEX THERAPEUTICS INC NEW

SOLE
COM NEW
Shares761.40K
TypeSH
Market value$21.4K
3.69%
Sole
761.40K
Shared
0.00
None
0.00

SPDR SER TR

SOLE
S&P BIOTECH
Shares243.40K
TypeSH
Market value$19.3K
3.33%
Sole
243.40K
Shared
0.00
None
0.00

MIRATI THERAPEUTICS INC

SOLE
COM
Shares221K
TypeSH
Market value$15.4K
2.66%
Sole
221K
Shared
0.00
None
0.00

VERONA PHARMA PLC

SOLE
SPONSORED ADS
Shares1.32M
TypeSH
Market value$13.5K
2.34%
Sole
1.32M
Shared
0.00
None
0.00

VERA THERAPEUTICS INC

SOLE
CL A
Shares533.26K
TypeSH
Market value$11.4K
1.96%
Sole
533.26K
Shared
0.00
None
0.00

HARMONY BIOSCIENCES HLDGS IN

SOLE
COM
Shares243.50K
TypeSH
Market value$10.8K
1.86%
Sole
243.50K
Shared
0.00
None
0.00

INTRA-CELLULAR THERAPIES INC

SOLE
COM
Shares220.95K
TypeSH
Market value$10.3K
1.77%
Sole
220.95K
Shared
0.00
None
0.00

STOKE THERAPEUTICS INC

SOLE
COM
Shares763.46K
TypeSH
Market value$9.8K
1.69%
Sole
763.46K
Shared
0.00
None
0.00

BRIDGEBIO PHARMA INC

SOLE
COM
Shares933.74K
TypeSH
Market value$9.3K
1.60%
Sole
933.74K
Shared
0.00
None
0.00

ALPINE IMMUNE SCIENCES INC

SOLE
COM
Shares1.23M
TypeSH
Market value$8.8K
1.52%
Sole
1.23M
Shared
0.00
None
0.00

ASCENDIS PHARMA A/S

SOLE
SPONSORED ADR
Shares83.50K
TypeSH
Market value$8.6K
1.49%
Sole
83.50K
Shared
0.00
None
0.00

KARUNA THERAPEUTICS INC

SOLE
COM
Shares34.50K
TypeSH
Market value$7.8K
1.34%
Sole
34.50K
Shared
0.00
None
0.00

ALNYLAM PHARMACEUTICALS INC

SOLE
COM
Shares37.30K
TypeSH
Market value$7.5K
1.29%
Sole
37.30K
Shared
0.00
None
0.00

FATE THERAPEUTICS INC

SOLE
COM
Shares331.10K
TypeSH
Market value$7.4K
1.28%
Sole
331.10K
Shared
0.00
None
0.00

XILIO THERAPEUTICS INC

SOLE
COM
Shares2.42M
TypeSH
Market value$7.1K
1.22%
Sole
2.42M
Shared
0.00
None
0.00

AVIDITY BIOSCIENCES INC

SOLE
COM
Shares379.63K
TypeSH
Market value$6.2K
1.07%
Sole
379.63K
Shared
0.00
None
0.00

4D MOLECULAR THERAPEUTICS IN

SOLE
COM
Shares500K
TypeSH
Market value$4.0K
0.69%
Sole
500K
Shared
0.00
None
0.00

NUVALENT INC

SOLE
COM
Shares200K
TypeSH
Market value$3.9K
0.67%
Sole
200K
Shared
0.00
None
0.00

JOUNCE THERAPEUTICS INC

SOLE
COM
Shares1.40M
TypeSH
Market value$3.3K
0.57%
Sole
1.40M
Shared
0.00
None
0.00
Page 1 of 2
OCTAGON CAPITAL ADVISORS LP 13F Holdings โ€” 35 Positions | Finecho